1 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 150 mL in 150 mL Baxter Intravia Bag, Service Code 2K9232, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-032-95
Published July 27, 2016 · Recall initiated: May 5, 2016
Summary
FDA records drug Class II recall D-1374-2016, published July 27, 2016 and initiated May 5, 2016. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: 361 bags; Lot: Lot Number 160460204M , Exp. Date 5/10/2016 ; Lot Number 160560170M , Exp. Date 5/20/2016 ; Lot Number 160700007M , Exp. Date 6/2/2016 ; Lot Number 160810176M , Exp. Date 6/14/2016 ; Lot Number 160830325M , Exp. Date 6/16/2016 ; Lot Number 160880270M , Exp. Date 6/21/2016 ; Lot Number 160890245M , Exp. Date 6/22/2016 ; Lot Number 160900144M , Exp. Date 6/23/2016 ; Lot Number 160950241M , Exp. Date 6/28/2016 ; Lot Number 161080135M , Exp. Date 7/11/2016 . Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmedium Services, LLC
- Distributor
- Nationwide
- Lot
- Lot Number 160460204M , Exp. Date 5/10/2016 ; Lot Number 160560170M , Exp. Date 5/20/2016 ; Lot Number 160700007M , Exp. Date 6/2/2016 ; Lot Number 160810176M , Exp. Date 6/14/2016 ; Lot Number 160830325M , Exp. Date 6/16/2016 ; Lot Number 160880270M , Exp. Date 6/21/2016 ; Lot Number 160890245M , Exp. Date 6/22/2016 ; Lot Number 160900144M , Exp. Date 6/23/2016 ; Lot Number 160950241M , Exp. Date 6/28/2016 ; Lot Number 161080135M , Exp. Date 7/11/2016 ;
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00January 1, 2020
- FDAFentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%,December 26, 2018
- FDA1 mcg/mL Fentanyl Citrate and 0.08% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 mL in 100July 27, 2016
- FDA1 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 100 ml inJuly 27, 2016
Questions about this recall
Was 1 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 150 mL in 150 mL Baxter Intravia Bag, Service Code 2K9232, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-032-95 recalled?
Yes. FDA published recall D-1374-2016 on July 27, 2016. Reported hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail